RKTS-33, an Epoxycyclohexenone Derivative That Specifically Inhibits Fas Ligand-Dependent Apoptosis in CTL-Mediated Cytotoxicity

  • MITSUI Tomokazu
    Center for Biological Resources and Informatics, Tokyo Institute of Technology
  • MIYAKE Yasunobu
    Center for Biological Resources and Informatics, Tokyo Institute of Technology Antibiotics Laboratory, Discovery Research Institute, RIKEN
  • KAKEYA Hideaki
    Antibiotics Laboratory, Discovery Research Institute, RIKEN
  • HAYASHI Yujiro
    Department of Industrial Chemistry, Faculty of Engineering, Tokyo University of Science
  • OSADA Hiroyuki
    Antibiotics Laboratory, Discovery Research Institute, RIKEN
  • KATAOKA Takao
    Center for Biological Resources and Informatics, Tokyo Institute of Technology

Search this article

Abstract

Cytotoxic T lymphocytes (CTLs) eliminate virus-infected cells and tumor cells by two distinct killing pathways, mediated by lytic granules containing perforin and by Fas ligand (FasL). ECH [(2R,3R,4S)-2,3-epoxy-4-hydroxy-5-hydroxymethyl-6-(1E)-propenyl-cyclohex-5-en-1-one] has been shown to inhibit FasL-dependent apoptosis or the killing pathway in short-term culture. However, since ECH exhibited cell toxicity in long-term culture, we attempted the synthesis of less toxic epoxycyclohexenone derivatives. In the present study, we found that RKTS-33 [(2R,3R,4S)-2,3-epoxy-4-hydroxy-5-hydroxymethyl-cyclohex-5-en-1-one] has cell toxicity lower than ECH in long-term culture, and further investigated the inhibitory effect of RKTS-33 on CTL-mediated killing pathways. RKTS-33 did not affect cell-surface expression of FasL upon CD3 stimulation, but profoundly inhibited the FasL-dependent killing pathway mediated by CD4+ and CD8+ CTLs, indicating that RKTS-33 specifically blocks target cell apoptosis but not CTL function. By contrast, RKTS-33 did not affect the perforin-dependent killing pathway in CD8+ CTLs. These results indicate that RKTS-33 is a specific inhibitor of the FasL-dependent killing pathway in CTL-mediated cytotoxicity.

Journal

Citations (4)*help

See more

References(28)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top